|
|
|
|
Lactate as a possible predictor of malignency in head-and-neck carcinoma
T. ZIEBART, Universitätsklinikum Mainz, Germany, Germany, S. WALENTA, Universitätsklinikum Mainz, Germany, W. MÜLLER-KLIESER, Universitätsklinikum Mainz, B. AL-NAWAS, Universitatsklinkum Mainz, Germany, and W. WAGNER, Johannes-Gutenberg-University of Mainz, Germany | Objective: Aim of this study: 1) Quantifcation
of metabolism and energy turnover in squamous cell carcinoma of the head and
neck region compared to normal oral mucosa ; 2) Correlation
of these metabolism parameters to the clinical prognosis
Methods: Flash cryopreserved biopsies
were analysed by bioluminescence imaging. This metabolic imaging technique
allows to measure structures associated with the local metabolic concentration
exclusively in areas of the biopsy. Gene expression of the lactat dehydrogenase
(LDH) was analyzed by semi-quantitative reverse-transcriptase-PCR and
Western-Blot in tumor slices. Healthy oral mucosa served as control. The
patients survival served as a clinical parameter.
Results:
Collective | N | Glucose [µmol/g] | Lactate [µmol/g] | Median | Min | Max | Median | Min | Max | Normal tissue | 11 | 2,92 | 1,27 | 3,75 | 3,73 | 1,01 | 5,5 | Tumor tissue | 19 | 1,26 | 0,25 | 3,16 | 10,45 | 5,86 | 19,97 |
RNA as well as protein expression show that the LDH is significantly
up-regulated in carcinoma of the head and neck region in comparison with normal
gingiva. A comparable result was found between tumors with and without lymph
node metastasis. Kaplan-Meier-Survival analysis of a group with high level
lactate tumors and a group of low level tumors shows a significantly decreased
survival rate for the high level lactate group.
Conclusion: The
quantitative and structure-associated determination of lactate in clinical
biopsies revealed differences between normal and tumour
tissue. These metabolic parameters. of primary tumors seem
to be promising prognostic parameters in the first diagnosis of SCC in the
future.
| Seq #39 - Head and Neck Cancer, Dental Implants 9:00 AM-10:30 AM, Thursday, July 3, 2008 Metro Toronto Convention Centre Room 709 |
Back to the Oral & Maxillofacial Surgery Program
|
|